Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
43.32
+1.62 (3.88%)
Nov 10, 2026, 4:08 PM HKT
Biocytogen Pharmaceuticals (Beijing) Employees
Biocytogen Pharmaceuticals (Beijing) had 1,922 employees as of June 30, 2026. The number of employees increased by 479 or 33.19% since the number was reported on December 31, 2025. That makes Biocytogen Pharmaceuticals (Beijing) the 10,494th largest employer in the world and 779th in Hong Kong.
Employees
1,922
Change
479
Growth
33.19%
Revenue / Employee
1.49M HKD
Profits / Employee
301.19K HKD
Market Cap
35.52B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1,922 | 479 | 33.19% |
| Dec 31, 2025 | 1,443 | 326 | 29.19% |
| Dec 31, 2024 | 1,117 | 51 | 4.78% |
| Dec 31, 2023 | 1,066 | -282 | -20.92% |
| Dec 31, 2022 | 1,348 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Genscript Biotech | 6,135 |
| 3SBio | 6,068 |
| Shanghai Henlius Biotech | 4,082 |
| Akeso | 4,082 |
| RemeGen | 3,145 |
| Shanghai Junshi Biosciences | 3,055 |
| Zai Lab | 1,784 |
| Keymed Biosciences | 1,768 |
Biocytogen Pharmaceuticals (Beijing) News
- 12 days ago - Biocytogen Pharmaceuticals (Beijing) Earnings release: Q3 2026 - Filings
- 2 months ago - Biocytogen Pharmaceuticals (Beijing) Earnings release: H1 2026 - Filings
- 3 months ago - Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals - South China Morning Post
- 4 months ago - Court Clears Biocytogen's RenNano® in Landmark Patent Dispute Against Harbour - Business Upturn
- 6 months ago - Biocytogen Pharmaceuticals (Beijing) Earnings release: Q1 2026 - Filings
- 7 months ago - Biocytogen Pharmaceuticals (Beijing) Earnings release: H2 2025 - Filings
- 9 months ago - Strengthening Translational Research in India: GVSAP and Biocytogen Expand Collaboration - Business Upturn
- 1 year ago - Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Financial Post